Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Turk J Med Sci ; 54(3): 588-597, 2024.
Article in English | MEDLINE | ID: mdl-39049994

ABSTRACT

Background/aim: Amnestic mild cognitive impairment (aMCI) is a risk factor for dementia, and thus, it is of interest to enlighten specific brain atrophy patterns in aMCI patients. We aim to define the longitudinal atrophy pattern in subcortical structures and its effect on cognition in patients with aMCI. Materials and methods: Twenty patients with aMCI and 20 demographically matched healthy controls with baseline and longitudinal structural magnetic resonance imaging scans and neuropsychological assessments were studied. The algorithm FIRST (FMRIB's integrated registration and segmentation tool) was used to obtain volumes of subcortical structures (thalamus, putamen, caudate nucleus, nucleus accumbens, globus pallidus, hippocampus, and amygdala). Correlations between volumes and cognitive performance were assessed. Results: Compared with healthy controls, aMCI demonstrated subcortical atrophies in the hippocampus (p = 0.001), nucleus accumbens (p = 0.003), and thalamus (p = 0.003) at baseline. Significant associations were found for the baseline volumes of the thalamus, nucleus accumbens, and hippocampus with memory, the thalamus with visuospatial skills. Conclusion: aMCI demonstrated subcortical atrophies associated with cognitive deficits. The thalamus, nucleus accumbens, and hippocampus may provide additional diagnostic information for aMCI.


Subject(s)
Atrophy , Cognitive Dysfunction , Magnetic Resonance Imaging , Humans , Cognitive Dysfunction/pathology , Male , Female , Atrophy/pathology , Aged , Longitudinal Studies , Middle Aged , Neuropsychological Tests , Amnesia/pathology , Amnesia/diagnostic imaging , Cognition/physiology , Brain/pathology , Brain/diagnostic imaging , Hippocampus/pathology , Hippocampus/diagnostic imaging , Case-Control Studies
2.
J Alzheimers Dis ; 100(1): 333-343, 2024.
Article in English | MEDLINE | ID: mdl-38875037

ABSTRACT

Background: Amnestic syndrome of the hippocampal type (ASHT) in Memory Clinics is a presentation common to Alzheimer's disease (AD). However, ASHT can be found in other neurodegenerative disorders. Objective: To compare brain morphometry including hippocampal volumes between amnestic older adults with and without AD pathology and investigate their relationship with memory performance and cerebrospinal fluid (CSF) biomarkers. Methods: Brain morphometry of 92 consecutive patients (72.5±6.8 years old; 39% female) with Free and Cued Selective Recall Reminding Test (FCSRT) total recall < 40/48 was assessed with an automated algorithm and compared between AD and non-AD patients, as defined by CSF biomarkers. Results: AD and non-AD patients presented comparable brain morphology. Total recall was associated to hippocampal volume irrespectively from AD pathology. Conclusions: Brain morphometry, including hippocampal volumes, is similar between AD and non-AD older adults with ASHT evaluated in a Memory Clinic, underlying the importance of using molecular biomarkers for the diagnosis of AD.


Subject(s)
Alzheimer Disease , Amnesia , Brain , Hippocampus , Magnetic Resonance Imaging , Humans , Female , Aged , Male , Alzheimer Disease/pathology , Amnesia/pathology , Amnesia/diagnostic imaging , Hippocampus/pathology , Hippocampus/diagnostic imaging , Brain/pathology , Brain/diagnostic imaging , Biomarkers/cerebrospinal fluid , Neuropsychological Tests , Aged, 80 and over , Mental Recall/physiology , Amyloid beta-Peptides/cerebrospinal fluid , Organ Size
3.
Brain Behav ; 14(6): e3601, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38898628

ABSTRACT

OBJECTIVE: To explore the functional connectivity (FC) characteristics of the episodic memory network (EMN) in amnestic mild cognitive impairment (aMCI) patients with different levels of executive function (EF). METHODS: This study included 76 participants from the Alzheimer's Disease Neuroimaging Initiative database, comprising 23 healthy controls (HCs) and 53 aMCI patients. Based on EF levels, aMCI patients were categorized into aMCI-highEF and aMCI-lowEF groups. Cognitive function scores, pathological markers (cerebrospinal fluid ß-amyloid, total tau protein, phosphorylated tau protein, AV45-PET, and FDG-PET), and functional magnetic resonance imaging were collected and compared among the three groups. Seed-based FC analysis was used to examine differences in the EMN among the groups, and partial correlation analysis was employed to investigate the relationship between changes in FC and cognitive function scores as well as pathological markers. RESULTS: Compared to the aMCI-highEF group, the aMCI-lowEF group exhibited more severe cognitive impairment, decreased cerebral glucose metabolism, and elevated AV45 levels. Significant FC differences in the left superior temporal gyrus (STG) of the EMN were observed among the three groups. Post hoc analysis revealed that the aMCI-lowEF group had increased FC in the left STG compared to the HCs and aMCI-highEF groups, with statistically significant differences. Correlation analysis showed a significant negative correlation between the differences in FC in the left STG of aMCI-highEF and aMCI-lowEF groups and Rey Auditory Verbal Learning Test forgetting scores. Receiver operator characteristic curve analysis indicated an area under the curve of 0.741 for distinguishing between aMCI-highEF and aMCI-lowEF groups based on FC of left STG, with a sensitivity of 0.808 and a specificity of 0.667. CONCLUSION: aMCI-lowEF exhibits characteristic changes in FC within the EMN, providing theoretical support for the role of EF in mediating EMN alterations and, consequently, impacting episodic memory function.


Subject(s)
Amnesia , Cognitive Dysfunction , Executive Function , Magnetic Resonance Imaging , Memory, Episodic , Positron-Emission Tomography , Humans , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/etiology , Male , Female , Aged , Executive Function/physiology , Amnesia/physiopathology , Amnesia/diagnostic imaging , Middle Aged , Neuropsychological Tests , Brain/physiopathology , Brain/diagnostic imaging , Nerve Net/physiopathology , Nerve Net/diagnostic imaging
4.
Brain Res Bull ; 214: 110995, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38844172

ABSTRACT

Tongue coating affects cognition, and cognitive decline at early stage also showed relations to functional and structural remodeling of superior temporal sulcus (STS) in amnestic mild cognitive impairment (aMCI). The potential correlation between disparate cognitive manifestations in aMCI patients with different tongue coatings, and corresponding mechanisms of STS remodeling remains uncharted. In this case-control study, aMCI patients were divided into thin coating (n = 18) and thick coating (n = 21) groups. All participants underwent neuropsychological evaluations and multimodal magnetic resonance imaging. Group comparisons were conducted in clinical assessments and neuroimaging measures of banks of the STS (bankssts). Generalized linear models were constructed to explore relationships between neuroimaging measures and cognition. aMCI patients in the thick coating group exhibited significantly poorer immediate and delayed recall and slower information processing speed (IPS) (P < 0.05), and decreased functional connectivity (FC) of bilateral bankssts with frontoparietal cortices (P < 0.05, AlphaSim corrected) compared to the thin coating group. It was found notable correlations between cognition encompassing recall and IPS, and FC of bilateral bankssts with frontoparietal cortices (P < 0.05, Bonferroni's correction), as well as interaction effects of group × regional homogeneity (ReHo) of right bankssts on the first immediate recall (P < 0.05, Bonferroni's correction). aMCI patients with thick coating exhibited poor cognitive performance, which might be attributed to decreased FC seeding from bankssts. Our findings strengthen the understanding of brain reorganization of STS via which tongue coating status impacts cognition in patients with aMCI.


Subject(s)
Cognitive Dysfunction , Magnetic Resonance Imaging , Temporal Lobe , Tongue , Humans , Cognitive Dysfunction/physiopathology , Male , Female , Aged , Temporal Lobe/physiopathology , Temporal Lobe/diagnostic imaging , Magnetic Resonance Imaging/methods , Tongue/physiopathology , Case-Control Studies , Middle Aged , Neuropsychological Tests , Amnesia/physiopathology , Amnesia/diagnostic imaging , Mental Recall/physiology
5.
Int J Mol Sci ; 25(11)2024 May 21.
Article in English | MEDLINE | ID: mdl-38891795

ABSTRACT

The purpose of this study was to investigate whether plasma biomarkers can help to diagnose, differentiate from Alzheimer disease (AD), and stage cognitive performance in patients with positron emission tomography (PET)-confirmed primary age-related tauopathy, termed tau-first cognitive proteinopathy (TCP) in this study. In this multi-center study, we enrolled 285 subjects with young-onset AD (YOAD; n = 55), late-onset AD (LOAD; n = 96), TCP (n = 44), and cognitively unimpaired controls (CTL; n = 90) and analyzed plasma Aß42/Aß40, pTau181, neurofilament light (NFL), and total-tau using single-molecule assays. Amyloid and tau centiloids reflected pathological burden, and hippocampal volume reflected structural integrity. Receiver operating characteristic curves and areas under the curves (AUCs) were used to determine the diagnostic accuracy of plasma biomarkers compared to hippocampal volume and amyloid and tau centiloids. The Mini-Mental State Examination score (MMSE) served as the major cognitive outcome. Logistic stepwise regression was used to assess the overall diagnostic accuracy, combining fluid and structural biomarkers and a stepwise linear regression model for the significant variables for MMSE. For TCP, tau centiloid reached the highest AUC for diagnosis (0.79), while pTau181 could differentiate TCP from YOAD (accuracy 0.775) and LOAD (accuracy 0.806). NFL reflected the clinical dementia rating in TCP, while pTau181 (rho = 0.3487, p = 0.03) and Aß42/Aß40 (rho = -0.36, p = 0.02) were significantly correlated with tau centiloid. Hippocampal volume (unstandardized ß = 4.99, p = 0.01) outperformed all of the fluid biomarkers in predicting MMSE scores in the TCP group. Our results support the superiority of tau PET to diagnose TCP, pTau181 to differentiate TCP from YOAD or LOAD, and NFL for functional staging.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Biomarkers , Positron-Emission Tomography , tau Proteins , Humans , Alzheimer Disease/blood , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/diagnosis , tau Proteins/blood , Biomarkers/blood , Male , Female , Positron-Emission Tomography/methods , Aged , Amyloid beta-Peptides/blood , Middle Aged , Cognition , Hippocampus/diagnostic imaging , Hippocampus/pathology , Hippocampus/metabolism , Neurofilament Proteins/blood , Aged, 80 and over , Amnesia/blood , Amnesia/diagnostic imaging , Amnesia/diagnosis , ROC Curve , Clinical Relevance
6.
J Alzheimers Dis ; 100(3): 775-782, 2024.
Article in English | MEDLINE | ID: mdl-38905049

ABSTRACT

The role of the cerebellum in amnestic mild cognitive impairment (aMCI), typically a prodromal stage of Alzheimer's disease, is not fully understood. We studied the lobule-specific cerebello-cerebral connectivity in 15 cognitively normal and 16 aMCI using resting-state functional MRI. Our analysis revealed weaker connectivity between the cognitive cerebellar lobules and parietal lobe in aMCI. However, stronger connectivity was observed in the cognitive cerebellar lobules with certain brain regions, including the precuneus cortex, posterior cingulate gyrus, and caudate nucleus in participants with worse cognition. Leveraging these measurable changes in cerebello-parietal functional networks in aMCI could offer avenues for future therapeutic interventions.


Subject(s)
Amnesia , Cerebellum , Cognitive Dysfunction , Magnetic Resonance Imaging , Parietal Lobe , Humans , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/diagnostic imaging , Male , Female , Aged , Cerebellum/diagnostic imaging , Cerebellum/physiopathology , Parietal Lobe/physiopathology , Parietal Lobe/diagnostic imaging , Amnesia/physiopathology , Amnesia/diagnostic imaging , Neural Pathways/physiopathology , Neural Pathways/diagnostic imaging , Neuropsychological Tests , Middle Aged
7.
Psychogeriatrics ; 24(4): 830-837, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38692585

ABSTRACT

BACKGROUND: Drivers with dementia are at a higher risk of motor vehicle accidents. The characteristics of driving behaviour of patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) have not been fully elucidated. We investigated driving ability and its relationship with cognitive function and magnetic resonance imaging (MRI) morphometry indicators. METHODS: The driving abilities of 19 patients with AD and 11 with amnestic MCI (aMCI) were evaluated using a driving simulator. The association between each driving ability parameter and the Mini-Mental State Examination (MMSE) score or voxel-based specific regional analysis system for AD (VSRAD) was assessed. RESULTS: Patients with AD made a significantly higher number of operational errors than those with aMCI in attention allocation in the complex task test (P = 0.0008). The number of operational errors in attention allocation in the complex task test significantly and negatively correlated with MMSE scores in all participants (r = -0.4354, P = 0.0162). The decision time in the selective reaction test significantly and positively correlated with the severity and extent of medial temporal structural atrophy (r = 0.4807, P = 0.0372; r = 0.4862, P = 0.0348; respectively). CONCLUSION: An increase in the operational errors for attention allocation in the complex task test could be a potential indicator of progression from aMCI to AD. Atrophy of the medial temporal structures could be a potential predictor of impaired judgement in driving performance in aMCI and AD. A driving simulator could be useful for evaluating the driving abilities of individuals with aMCI and AD.


Subject(s)
Alzheimer Disease , Automobile Driving , Cognitive Dysfunction , Magnetic Resonance Imaging , Neuropsychological Tests , Humans , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology , Automobile Driving/psychology , Male , Female , Aged , Magnetic Resonance Imaging/methods , Neuropsychological Tests/statistics & numerical data , Aged, 80 and over , Mental Status and Dementia Tests/statistics & numerical data , Amnesia/diagnostic imaging , Attention/physiology , Atrophy/pathology
8.
Alzheimers Res Ther ; 16(1): 97, 2024 05 03.
Article in English | MEDLINE | ID: mdl-38702802

ABSTRACT

BACKGROUND: The locus coeruleus (LC) and the nucleus basalis of Meynert (NBM) are altered in early stages of Alzheimer's disease (AD). Little is known about LC and NBM alteration in limbic-predominant age-related TDP-43 encephalopathy (LATE) and frontotemporal dementia (FTD). The aim of the present study is to investigate in vivo LC and NBM integrity in patients with suspected-LATE, early-amnestic AD and FTD in comparison with controls. METHODS: Seventy-two participants (23 early amnestic-AD patients, 17 suspected-LATE, 17 FTD patients, defined by a clinical-biological diagnosis reinforced by amyloid and tau PET imaging, and 15 controls) underwent neuropsychological assessment and 3T brain MRI. We analyzed the locus coeruleus signal intensity (LC-I) and the NBM volume as well as their relation with cognition and with medial temporal/cortical atrophy. RESULTS: We found significantly lower LC-I and NBM volume in amnestic-AD and suspected-LATE in comparison with controls. In FTD, we also observed lower NBM volume but a slightly less marked alteration of the LC-I, independently of the temporal or frontal phenotype. NBM volume was correlated with the global cognitive efficiency in AD patients. Strong correlations were found between NBM volume and that of medial temporal structures, particularly the amygdala in both AD and FTD patients. CONCLUSIONS: The alteration of LC and NBM in amnestic-AD, presumed-LATE and FTD suggests a common vulnerability of these structures to different proteinopathies. Targeting the noradrenergic and cholinergic systems could be effective therapeutic strategies in LATE and FTD.


Subject(s)
Alzheimer Disease , Basal Nucleus of Meynert , Frontotemporal Dementia , Locus Coeruleus , Magnetic Resonance Imaging , Humans , Frontotemporal Dementia/diagnostic imaging , Frontotemporal Dementia/pathology , Male , Locus Coeruleus/diagnostic imaging , Locus Coeruleus/pathology , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology , Female , Aged , Magnetic Resonance Imaging/methods , Basal Nucleus of Meynert/diagnostic imaging , Basal Nucleus of Meynert/pathology , Middle Aged , Neuropsychological Tests , Amnesia/diagnostic imaging , Positron-Emission Tomography/methods
9.
Ann Clin Transl Neurol ; 11(5): 1236-1249, 2024 May.
Article in English | MEDLINE | ID: mdl-38553802

ABSTRACT

OBJECTIVES: Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and treatment. This study assessed PET biomarkers, including brain glucose metabolism, tau, and amyloid load, in a series of comparable aMCI at baseline, clinically evaluated at follow-up. METHODS: We included 72 aMCI subjects from Geneva Memory Center (N = 31) and ADNI cohorts (N = 41), selected based on available FDG-PET, tau-PET, amyloid-PET, and clinical follow-up (2.3 years ± 1.2). A data-driven algorithm classified brain metabolic patterns into subtypes that were then compared for clinical and PET biomarker measures and cognitive decline. Voxel-wise comparisons were performed both with FDG-PET and tau-PET data. RESULTS: The algorithm classified three metabolic subtypes, namely "Hippocampal-sparing with cortical hypometabolism" (Type1; N = 27), "Hippocampal and cortical hypometabolism" (Type 2; N = 23), and "Medial temporal hypometabolism" (Type 3; N = 22). Amyloid positivity and tau accumulation in the medial temporal and neocortical regions characterized Type 1 and Type 2, whereas Type 3 showed no significant tau pathology, variable amyloid positivity, and stability at follow-up. All tau-positive patients, independently of the FDG-based subtype, showed faster cognitive decline. INTERPRETATION: aMCI subjects can differ in metabolic patterns, tau and amyloid pathology, and clinical progression. Here, we complemented with PET tau biomarker the specific brain hypometabolic patterns at the individual level in the prodromal phase, contributing to the patient's classification. Tau PET is the most accurate biomarker in supporting or excluding the AD diagnosis in aMCI across metabolic subtypes and also predicting the risk of decline.


Subject(s)
Amnesia , Cognitive Dysfunction , Fluorodeoxyglucose F18 , Positron-Emission Tomography , tau Proteins , Humans , Male , Female , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/diagnosis , Aged , tau Proteins/metabolism , Amnesia/diagnostic imaging , Amnesia/metabolism , Prognosis , Aged, 80 and over , Middle Aged , Disease Progression , Brain/diagnostic imaging , Brain/metabolism , Biomarkers/metabolism , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Alzheimer Disease/diagnosis , Follow-Up Studies
10.
Neuropsychologia ; 194: 108780, 2024 02 15.
Article in English | MEDLINE | ID: mdl-38159800

ABSTRACT

Language use has long been understood to be tailored to the intended addressee, a process termed audience design. Audience design is reflected in multiple aspects of language use, including adjustments based on the addressee's knowledge about the topic at hand. In group settings, audience design depends on representations of multiple individuals, each of whom may have different knowledge about the conversational topic. A central question, then, concerns how these representations are encoded and retrieved in multiparty conversation where successful conversation requires keeping track of who knows what. In the present research, we probe the biological memory systems that are involved in this process of multiparty audience design. We present the results of two experiments that compare language use in persons with bilateral hippocampal damage and severe declarative memory impairment (amnesia), and demographically matched neurotypical comparison participants. Participants played a game in which they discussed abstract images with one partner in conversation, and then discussed the images again with the same partner or with a new partner in a three-party conversation. Neurotypical participants' language use reflected newly formed representations of which partner was familiar with which images. Participants with amnesia showed evidence of partner-specific audience design in multiparty conversation but it was attenuated, especially when success required rapid alternations between representations of common ground. The findings suggest partial independence of the formation and use of partner-specific representations from the hippocampal-dependent declarative memory system and highlight the unique contributions of the declarative memory system to flexible and dynamic language use.


Subject(s)
Communication , Language , Humans , Amnesia/diagnostic imaging , Hippocampus/diagnostic imaging , Knowledge
11.
Neurocase ; 29(6): 186-190, 2023 12.
Article in English | MEDLINE | ID: mdl-38700142

ABSTRACT

Isolated fornix anterior column infarction has rarely been described and is difficult to assess accurately using conventional magnetic resonance imaging (MRI). We report the case of a 75-year-old female who experienced acute anterograde amnesia. MRI performed within 24 h after amnesia onset showed an isolated infarction of the bilateral anterior columns of the fornix on diffusion-weighted imaging (DWI). Her symptoms persisted for up to 50 days, and diffusion tensor imaging (DTI) showed disruption of the fiber tracts of the fornix. when acute amnesia syndrome onset, fornix anterior column infarction should be considered, and optimized DWI and DTI methods are needed to study the fornix in vivo in future research.


Subject(s)
Diffusion Tensor Imaging , Fornix, Brain , Humans , Female , Fornix, Brain/diagnostic imaging , Fornix, Brain/pathology , Aged , Diffusion Magnetic Resonance Imaging , Amnesia, Anterograde/etiology , Amnesia/etiology , Amnesia/diagnostic imaging , Cerebral Infarction/diagnostic imaging , Cerebral Infarction/complications
SELECTION OF CITATIONS
SEARCH DETAIL